Market Tracker

05/31 5:16pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.21
Delayed Data
As of 4:00pm ET
 +0.04 / +1.84%
Today’s Change
1.26
Today|||52-Week Range
6.49
-42.15%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close2.17
Today’s open2.16
Day’s range2.16 - 2.25
Volume16,411
Average volume (3 months)38,755
Market cap$14.2M
Dividend yield--
Data as of 4:00pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
BNTCBenitec Biopharma Lt...-0.20-12.19%
RGBPRegen BioPharma Inc-0.01-11.01%
IGCIndia Globalization ...+0.03+6.64%
OXGNOXiGENE Inc+0.00+0.02%
Data as of 3:59pm ET, 05/31/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts